Cardiff Oncology Company Top Insiders

Cardiff Oncology Management Team Effectiveness

The company has return on total asset (ROA) of (0.3833) % which means that it has lost $0.3833 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6757) %, meaning that it created substantial loss on money invested by shareholders. Cardiff Oncology's management efficiency ratios could be used to measure how well Cardiff Oncology manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.53. The Cardiff Oncology's current Return On Capital Employed is estimated to increase to -0.61. At this time, Cardiff Oncology's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Cardiff Oncology's current Net Tangible Assets is estimated to increase to about 128.4 M, while Total Assets are projected to decrease to roughly 45.3 M. The Cardiff Oncology's current Common Stock Shares Outstanding is estimated to increase to about 46.9 M, while Net Loss is projected to decrease to (36.6 M).

Cardiff Oncology Workforce Comparison

Cardiff Oncology Insider Trading History

Cardiff Oncology Notable Stakeholders

The success or failure of an entity such as Cardiff Oncology often depends on how effective the management is. Cardiff Oncology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cardiff management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cardiff management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.